Indeed, in Africa,
Brazil and Asia, leprosy patients treated in the distant past are more likely than others to be infected not just with HCV but also with
HBV and the HTLV-1 retrovirus
.
However, the proportion of Cameroonians ever treated for trypanosomiasis or leprosy was lower than the 40–50% who became HCV-infected in some areas, implying that other interventions must have played a role as well.
50
–
54
In Cameroon, populations with a high HCV prevalence live in
Yaoundé or communities in the southern rain forest (
Figure 9
and
Map 5
). I initially believed that the HCV epidemic could have been driven by campaigns against yaws, for several reasons. First, the sheer numbers: from the mid-1930s till the late 1950s, in some regions, the whole population developed yaws within a few years and received antitreponemal drugs. Second, the age distribution: yaws was more common among children who had the opportunity to survive until the mid-1990s when HCV surveys were carried out. Third, the rise in incidence of yaws in Cameroun after 1935 corresponds chronologically to what can be inferred to be the period of highest HCV transmission. Fourth, the geographic distribution of HCV coincides with that of yaws, whose incidence was much higher in coastal and forested regions than in northern savannahs.
10
The same north–south gradient in yaws incidence was observed in the AEF, now mirrored by a higher HCV prevalence in southern
areas. In these countries, HCV prevalence is three to six times lower in
Pygmies than
Bantus, perhaps reflecting less intensive uptake of medical interventions among the former. There is also a north–south gradient in HTLV-1 prevalence, suggesting that this retrovirus may have been transmitted iatrogenically during the same interventions
.
7
,
55
–
58
But there was another common tropical disease with a marked north–south gradient in incidence: malaria. While malaria occurs throughout tropical Africa, its distribution is heterogeneous, in line with that of its vector, the female anopheline mosquito. The risk of malaria is quantified by the number of infective mosquito bites sustained each year by each person. In tropical Africa, the median number of infective bites is 77 per year, but in the rural and rainy areas of central Africa this number is generally ≥≥200. The record belongs to a village of Equatorial
Guinea, where humans sustain 1,030 infective bites per year, three per day! In large cities such as
Kinshasa and Brazzaville, the risk is lower (3–30 bites) because there is less stagnant water where the vectors can breed and many more humans in relation to the population of mosquitoes. But
one just has to drive fifteen kilometres to the semi-rural areas around Kinshasa and the risk goes up to 620 bites per year.
59
–
61
In the southern and forested areas of Cameroon, there is up to 4,000 mm of rain each year, compared to only 800 mm in the extreme north. The number of infective bites varies accordingly, with high values in the south-west of the country, and low values in the arid north. The risk of developing malaria, and of eventually needing to receive IV
quinine, varies along the same patterns. Thus malaria also correlated nicely with HCV distribution: a marked north–south gradient, a high incidence so that a large proportion of the population would receive parenteral antimalarial drugs at least once, the correct age distribution (more severe in children) and the correct time frame (the frequency of its parenteral treatment presumably increased in parallel with the development of fixed health services, from the 1930s onward).
To determine which interventions had really driven HCV transmission in southern Cameroon, we conducted a survey in the city of
Ebolowa, among individuals aged sixty years or more, 56% of whom were HCV-infected, the highest prevalence in the world, while 74% had antitreponemal antibodies, indicating prior
yaws or syphilis. We found no evidence that HCV had been transmitted during yaws treatment; many cases occurred during childhood and those treated parenterally received IM rather than IV injections.
62
However, 80% of the interviewees had experienced at least once in their lifetime an episode of illness for which IV injections were administered, and in about two-thirds of the cases this was for the treatment of malaria. HCV infection was associated with such treatments against malaria and, in the men’s case, with having been circumcised traditionally (during collective ceremonies, using knives or broken bottles). Because of its high frequency, the IV treatment of malaria had been the main driver of the transmission of HCV
.
62
We conducted a similar study of elderly individuals in a rural area of south-west Central African Republic (in and around Nola) which used to be, in the 1930s and 1940s, the most virulent focus of African trypanosomiasis. HCV prevalence was much lower than in Cameroun but we found that having been treated for trypanosomiasis in the 1930s and 1940s was associated with HCV, while having received injections of
pentamidine for the prevention of trypanosomiasis (between 1946 and 1953) was associated with infection with the
HTLV-1 retrovirus. The latter, although much less studied as a blood-borne agent, is an
interesting proxy for HIV-1, because it also originated from
Pan troglodytes
and infects CD4 lymphocytes (without causing AIDS). We also documented an extraordinary excess mortality amongst individuals who had been treated for sleeping sickness in the 1930s and 1940s. After excluding all other causes, we concluded that this excess mortality was probably caused by the iatrogenic transmission of HIV-1
.
63
Thus several medical interventions were associated with the iatrogenic transmission of blood-borne viruses, and it seems likely that the respective contribution of each varied from place to place, and also over time, depending on the local epidemiology of tropical diseases. And if interventions for the control of tropical diseases contributed to the transmission of HCV and HTLV-1 in Cameroun and AEF in the middle of the twentieth century, the same procedures must have amplified HIV-1 as well, from a single hunter/cook occupationally infected with SIV
cpz
to several hundred patients treated with
arsenicals or other drugs, a threshold beyond which sexual transmission could prosper
.
As reviewed in
Chapter 4
, the number of individuals occupationally infected with SIV
cpz
around 1921 was probably less than ten, but the probability that these individuals received IV or IM treatment for yaws, syphilis, trypanosomiasis, leprosy or malaria was very high, near 100% for those who lived in the areas hyperendemic for yaws and malaria. Once a second person had been iatrogenically infected with SIV
cpz
, he/she would develop a high viraemia during primary infection and for a few weeks would be extremely infectious for other patients treated in the same facility with the same hastily sterilised syringes and needles. A vicious circle could result.
In the
next chapter
, we will examine what happened at the same time in the Belgian Congo. It is unlikely that the original SIV
cpz
-infected cut hunter lived in this other colony, in which only a tiny fraction of the continent-wide populations of
P.t. troglodytes
were present. Furthermore, there is no evidence that the
bonobo, found only in the Belgian Congo, played a role in the emergence of HIV-1. However, the city of Léopoldville was at the heart of the early dissemination of the virus: this is the place where the two oldest HIV-1-containing specimens were discovered and the area with the highest genetic diversity of HIV-1 isolates in the world.